Targeting the cancer glycocalyx in salivary duct carcinoma: tumor‐associated mucin 1 (Tn‐MUC1) as a novel cell surface marker

Abstract Despite the use of targeted drugs for human epidermal growth factor receptor type 2 (HER2)‐positive salivary duct carcinoma (SDC) treatment, the overall prognosis for SDC remains poor. In this study, we aimed to investigate whether the glycocalyx of SDC cells serves as a potential cell surf...

Descripció completa

Dades bibliogràfiques

Autors principals:	Masashi Kuroki, Ryo Kawaura, Hiroyuki Tomita, Hirofumi Shibata, Toshimitsu Ohashi, Tomohiko Ishikawa, Hideshi Okada, Akira Hara, Takenori Ogawa
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-09-01
Col·lecció:	The Journal of Pathology: Clinical Research
Matèries:	glycocalyx glycan lectin Tn‐MUC1 salivary gland cancer salivary duct carcinoma
Accés en línia:	https://doi.org/10.1002/2056-4538.70042
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!